Skip to main content

Advertisement

Table 2 Tumour receptor status of patients imaged in the study

From: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer

Subject number HER-2 status (IHC) Oestrogen receptor (ER) status Progesterone receptor (PR) status
1 3+ ER negative PR negative
3 3+ ER negative PR positive
4 3+ ER positive PR negative
7 2+ ER positive PR negative
9 3+ ER positive PR positive
10 3+ ER negative PR negative
  1. IHC, immunohistochemistry.